Qassay has once again made a significant impact at the ADLM 2024, North America’s premier clinical diagnostics and medical devices fair. Held over three days at the McCormick Convention Center in Chicago, Qassay, a subsidiary of the P4Q group, introduced its state-of-the-art digital health ecosystem. This includes lateral flow readers, urine strip analyzers, and advanced digital platforms, Qassay PRO and Qassay Studio.
“We are very pleased with the reception our devices have received. Offering a solution with lab-grade performance combined with the advantages of a portable, cost-efficient reader allows us to be very competitive in the market,” Qassay representatives explained.
Qassay PRO
One of the most notable innovations showcased this year was the Qassay PRO platform. This advanced tool facilitates comprehensive reporting, test and reading visualization, enhanced traceability, and features like prevalence mapping and predictive alarm systems. Qassay’s participation in ADLM 2024 highlights their commitment to delivering high-quality, innovative solutions in the clinical diagnostics field. Their digital health ecosystem not only meets but exceeds market expectations, positioning Qassay as a leader in the industry.
